A novel BCMA CAR-T-cell therapy with optimized human scFv for treatment of relapsed/refractory multiple myeloma: results from phase I clinical trials.
Yang M, Zhang W, Yu K, Wang P, Jiang H, Chen L, Meng H, Weng Y, Tao R, Huang X, Xing C, Wang H, Wan J, Wang S, Dai L, Hendrix AY, Xiao J, Wang W, Ma H, Hao S, Jin J, Li Z, Jiang S.
Yang M, et al. Among authors: wang h, wang w, wang p, wang s.
Haematologica. 2022 Aug 1;107(8):1960-1965. doi: 10.3324/haematol.2022.280629.
Haematologica. 2022.
PMID: 35443566
Free PMC article.
No abstract available.